Baxter Price to Free Cash Flow Ratio 2010-2024 | BAX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

PE Ratio P/S Ratio Price/Book Ratio Price-FCF Ratio Net Worth

Baxter average price to free cash flow ratio for 2024 was 36.82, a 75.92% increase from 2023.
Baxter average price to free cash flow ratio for 2023 was 20.93, a 32.51% increase from 2022.
Baxter average price to free cash flow ratio for 2022 was 31.01, a 10.4% decline from 2021.

Price to free cash flow ratio can be defined as

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

PE Ratio P/S Ratio Price/Book Ratio Price-FCF Ratio Net Worth

Baxter average price to free cash flow ratio for 2024 was 36.82, a 75.92% increase from 2023.
Baxter average price to free cash flow ratio for 2023 was 20.93, a 32.51% increase from 2022.
Baxter average price to free cash flow ratio for 2022 was 31.01, a 10.4% decline from 2021.

Price to free cash flow ratio can be defined as

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$221.8B
Boston Scientific (BSX)	$151.4B
Stryker (SYK)	$149.1B
EssilorLuxottica (ESLOY)	$125.1B
Medtronic (MDT)	$117.2B
Lonza Group Ag (LZAGY)	$46B
Haleon (HLN)	$43.1B
GE HealthCare Technologies (GEHC)	$40.1B
ResMed (RMD)	$37.1B
Terumo (TRUMY)	$28.9B
Koninklijke Philips (PHG)	$25.6B
Zimmer Biomet Holdings (ZBH)	$22.1B
Insulet (PODD)	$19.4B
Smith & Nephew SNATS (SNN)	$11.1B
BellRing Brands (BRBR)	$10.1B
Sunny Optical Technology (SNPTF)	$10B
Bio-Rad Laboratories (BIO)	$10B
Demant (WILYY)	$8.7B
Lantheus Holdings (LNTH)	$6.4B
ICU Medical (ICUI)	$4.1B
Prestige Consumer Healthcare (PBH)	$3.9B
Envista Holdings (NVST)	$3.7B
Haemonetics (HAE)	$3.4B
Perrigo (PRGO)	$3.4B
GN Store Nord (GNNDY)	$3B
Shandong Weigao Medical Polymer (SHWGF)	$3B
QuidelOrtho (QDEL)	$2.9B
Neogen (NEOG)	$2.5B
LeMaitre Vascular (LMAT)	$2.2B
AtriCure (ATRC)	$2.1B